Brain Imaging Boosts Efforts to Lower Alzheimer's Risk
These imaging findings, according to the AJNR report, can help spur beneficial lifestyle changes in patients to reduce risk for Alzheimer's disease. Author Cyrus Raji, MD, PhD, of UCLA and an international team suggest a framework in which neuroradiologists work as part of a team of clinical neuroscientists (neurologists, psychiatrists, neuropsychologists, etc.) to use quantitative neuroradiology to prevent cognitive decline in populations at high risk for dementia — namely those with lifestyle, genetic, and other associated risk factors.
"I believe neuroradiology, and especially quantitative MRI technology, will have a huge impact in the future of diagnosis and treatment of Alzheimer's disease," says neurologist Majid Fotuhi, MD, PhD, of Johns Hopkins University. Dr. Fotuhi notes that "there is compelling evidence for the baseline size of hippocampus as a key determinant of risk for future cognitive decline," adding that a variety of lifestyle factors can cause atrophy or expansion in the volume of this "critical brain structure".
Such work is already being done at UCLA and other institutions that combine these approaches into novel ways to improve patient care. "We are working closely with neuroradiologists to redefine how we can reduce risk for Alzheimer's with quantitative neuroimaging that helps us pinpoint symptom-relevant volume loss in the brain and subsequent targets for tracking our lifestyle-based interventions," says Dr. David Merrill, a geriatric psychiatrist at UCLA Medical Center.
According to Howard Aizenstein, MD, PhD, a psychiatrist at University of Pittsburgh, "Recent advances have improved the ability to characterise imaging markers along the trajectory of Alzheimer's disease, starting in the pre-clinical phase. These markers, including structural, functional, and molecular imaging are being used in the AD diagnostic criteria [AA/NIA]."1
Dr. Fotuhi sees imaging findings as a unique motivator for patients to make positive lifestyle changes. "Patients seem to enjoy reviewing results of their imaging studies, more so than reading the results of their blood tests or other clinical evaluations. For example, they can see with their own eyes whether there are any strokes or atrophy in their brain. This can have a powerful impact on them and on their determination to make changes in their lifestyle in order to improve their brain health," he explains.
Among the lifestyle and risk factors that can be altered to potentially prevent cognitive declines are obesity, diet, sleep, diabetes, depression, hypertension, supplementation, smoking and physical activity. It estimated that as many as three million cases of Alzheimer's disease worldwide can be prevented with as little as a 10 percent reduction in the burden of preventable lifestyle.2
1 Sperling RA, Aisen PS, Beckett LA, et al. (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & dementia: The Journal of the Alzheimer's Association. 2011;7(3):280-292. doi:10.1016/j.jalz.2011.03.003.
2 Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10, 819-828.
Source and image credit: American Society of Neuroradiology
Published on : Mon, 8 Jun 2015
Print as PDF
Wide high-resolution touch screen for easy ECG review Full-size keyboard with a durable cover keeping dust, dirt and liquids away, making it highly hygienic ETM Sport, the first automated interpretation of athletes’ ECGs based on the Seattle...
The SonoSite EDGE II is a high-resolution, all-digital, 9.0-pound (4.1 kg) ultrasound system with a 12.1in. LED full-bleed glass display. The Edge II boosts improvements in cardiac and abdominal image quality through DirectClear Technology and a new wide-angle...
Sectra PACS is designed for a high production environment with stability and usability in focus. Highlights include functions to speed up oncology workflows such as anatomical linking and support for reviewing complex multiparametric MRI studies such...
Introducing a new chapter in ultrasound visualization technology. X-Porte was developed from the ground up to incorporate a breakthrough, proprietary beam-forming technology: XDI (Extreme Definition Imaging). This signal analysis algorithm shapes X-Porte's...
The SonoSite SII features a new touchscreen user interface with a clinician-driven menu logic that adaptively adjusts to your imaging needs – “what you need, is what you see”. An embedded dual transducer connector allows you to quickly switch between...